152 related articles for article (PubMed ID: 23526443)
1. The degree of liver injury determines the role of p21 in liver regeneration and hepatocarcinogenesis in mice.
Buitrago-Molina LE; Marhenke S; Longerich T; Sharma AD; Boukouris AE; Geffers R; Guigas B; Manns MP; Vogel A
Hepatology; 2013 Sep; 58(3):1143-52. PubMed ID: 23526443
[TBL] [Abstract][Full Text] [Related]
2. p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury.
Marhenke S; Buitrago-Molina LE; Endig J; Orlik J; Schweitzer N; Klett S; Longerich T; Geffers R; Sánchez Muñoz A; Dorrell C; Katz SF; Lechel A; Weng H; Krech T; Lehmann U; Dooley S; Rudolph KL; Manns MP; Vogel A
Gut; 2014 Sep; 63(9):1501-12. PubMed ID: 24092862
[TBL] [Abstract][Full Text] [Related]
3. Dynamic and coordinated regulation of KEAP1-NRF2-ARE and p53/p21 signaling pathways is associated with acetaminophen injury responsive liver regeneration.
Fan X; Chen P; Tan H; Zeng H; Jiang Y; Wang Y; Wang Y; Hou X; Bi H; Huang M
Drug Metab Dispos; 2014 Sep; 42(9):1532-9. PubMed ID: 25002747
[TBL] [Abstract][Full Text] [Related]
4. p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury Model.
Buitrago-Molina LE; Marhenke S; Becker D; Geffers R; Itzel T; Teufel A; Jaeschke H; Lechel A; Unger K; Markovic J; Sharma AD; Marquardt JU; Saborowski M; Saborowski A; Vogel A
Cell Mol Gastroenterol Hepatol; 2021; 11(5):1387-1404. PubMed ID: 33484913
[TBL] [Abstract][Full Text] [Related]
5. AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.
Ho C; Wang C; Mattu S; Destefanis G; Ladu S; Delogu S; Armbruster J; Fan L; Lee SA; Jiang L; Dombrowski F; Evert M; Chen X; Calvisi DF
Hepatology; 2012 Mar; 55(3):833-45. PubMed ID: 21993994
[TBL] [Abstract][Full Text] [Related]
6. Liver failure after extended hepatectomy in mice is mediated by a p21-dependent barrier to liver regeneration.
Lehmann K; Tschuor C; Rickenbacher A; Jang JH; Oberkofler CE; Tschopp O; Schultze SM; Raptis DA; Weber A; Graf R; Humar B; Clavien PA
Gastroenterology; 2012 Dec; 143(6):1609-1619.e4. PubMed ID: 22960658
[TBL] [Abstract][Full Text] [Related]
7. p21 ablation in liver enhances DNA damage, cholestasis, and carcinogenesis.
Ehedego H; Boekschoten MV; Hu W; Doler C; Haybaeck J; Gaβler N; Müller M; Liedtke C; Trautwein C
Cancer Res; 2015 Mar; 75(6):1144-55. PubMed ID: 25608711
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of wild-type p53-induced phosphatase 1 promotes liver regeneration in mice by direct activation of mammalian target of rapamycin.
Zhang L; Liu L; He Z; Li G; Liu J; Song Z; Jin H; Rudolph KL; Yang H; Mao Y; Zhang L; Zhang H; Xiao Z; Ju Z
Hepatology; 2015 Jun; 61(6):2030-41. PubMed ID: 25704606
[TBL] [Abstract][Full Text] [Related]
9. A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals.
da Silva CG; Studer P; Skroch M; Mahiou J; Minussi DC; Peterson CR; Wilson SW; Patel VI; Ma A; Csizmadia E; Ferran C
Hepatology; 2013 May; 57(5):2014-25. PubMed ID: 23238769
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.
Hui L; Zatloukal K; Scheuch H; Stepniak E; Wagner EF
J Clin Invest; 2008 Dec; 118(12):3943-53. PubMed ID: 19033664
[TBL] [Abstract][Full Text] [Related]
11. c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity.
Stepniak E; Ricci R; Eferl R; Sumara G; Sumara I; Rath M; Hui L; Wagner EF
Genes Dev; 2006 Aug; 20(16):2306-14. PubMed ID: 16912279
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage.
Buitrago-Molina LE; Pothiraju D; Lamlé J; Marhenke S; Kossatz U; Breuhahn K; Manns MP; Malek N; Vogel A
Hepatology; 2009 Aug; 50(2):500-9. PubMed ID: 19642171
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling.
García-Rodríguez JL; Barbier-Torres L; Fernández-Álvarez S; Gutiérrez-de Juan V; Monte MJ; Halilbasic E; Herranz D; Álvarez L; Aspichueta P; Marín JJ; Trauner M; Mato JM; Serrano M; Beraza N; Martínez-Chantar ML
Hepatology; 2014 May; 59(5):1972-83. PubMed ID: 24338587
[TBL] [Abstract][Full Text] [Related]
14. Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.
Chaturantabut S; Shwartz A; Evason KJ; Cox AG; Labella K; Schepers AG; Yang S; Acuña M; Houvras Y; Mancio-Silva L; Romano S; Gorelick DA; Cohen DE; Zon LI; Bhatia SN; North TE; Goessling W
Gastroenterology; 2019 May; 156(6):1788-1804.e13. PubMed ID: 30641053
[TBL] [Abstract][Full Text] [Related]
15. The reduction of cell death and proliferation by p27(Kip1) minimizes DNA damage in an experimental model of genotoxicity.
Ranchal I; González R; Bello RI; Ferrín G; Hidalgo AB; Linares CI; Aguilar-Melero P; González-Rubio S; Barrera P; Marchal T; Nakayama KI; de la Mata M; Muntané J
Int J Cancer; 2009 Nov; 125(10):2270-80. PubMed ID: 19672859
[TBL] [Abstract][Full Text] [Related]
16. Wuzhi tablet (Schisandra Sphenanthera extract) protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of NRF2-ARE and p53/p21 pathways.
Fan X; Jiang Y; Wang Y; Tan H; Zeng H; Wang Y; Chen P; Qu A; Gonzalez FJ; Huang M; Bi H
Drug Metab Dispos; 2014 Dec; 42(12):1982-90. PubMed ID: 25217484
[TBL] [Abstract][Full Text] [Related]
17. Dual Roles of Mammalian Target of Rapamycin in Regulating Liver Injury and Tumorigenesis in Autophagy-Defective Mouse Liver.
Ni HM; Chao X; Yang H; Deng F; Wang S; Bai Q; Qian H; Cui Y; Cui W; Shi Y; Zong WX; Wang Z; Yang L; Ding WX
Hepatology; 2019 Dec; 70(6):2142-2155. PubMed ID: 31095752
[TBL] [Abstract][Full Text] [Related]
18. 15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.
Lu D; Han C; Wu T
Oncogene; 2014 Feb; 33(9):1101-12. PubMed ID: 23542179
[TBL] [Abstract][Full Text] [Related]
19. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.
Wu H; Wade M; Krall L; Grisham J; Xiong Y; Van Dyke T
Genes Dev; 1996 Feb; 10(3):245-60. PubMed ID: 8595876
[TBL] [Abstract][Full Text] [Related]
20. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
